Dublin, Jan. 04, 2017 -- Research and Markets has announced the addition of the "Endometriosis - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for Endometriosis in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World.
Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
The report profiles 38 companies including many key and niche players such as
- AbbVie Inc. (US)
- AEterna Zentaris Inc. (Canada)
- Astellas Pharma Inc. (Japan)
- AstraZeneca Plc. (UK)
- Bayer HealthCare Pharmaceuticals, Inc. (US)
- Debiopharm Group (Switzerland)
- Evotec AG (Germany)
- Kissei Pharmaceutical Co., Ltd. (Japan)
- Neurocrine Biosciences, Inc. (US)
- ObsEva SA (Switzerland)
- Pfizer, Inc. (US)
- Repros Therapeutics, Inc. (US)
- Roivant Sciences Ltd. (US)
- Takeda Pharmaceutical Company Limited (Japan)
- ValiRx Plc (UK)
Key Topics Covered:
1. Industry Overview
2. Endometriosis & Its Treatment - An Overview
3. Treatment Of Endometriosis
4. Select Clinical Trials/Product Innovations & Approvals
5. Recent Industry Activity
6. Focus On Select Global Players
7. Global Market Perspective
Total Companies Profiled: 38 (including Divisions/Subsidiaries 40)
- The United States (11)
- Canada (3)
- Japan (6)
- Europe (15)
- - France (1)
- - Germany (3)
- - The United Kingdom (2)
- - Rest of Europe (9)
- Asia-Pacific (Excluding Japan) (4)
- Middle-East (1)
For more information about this report visit http://www.researchandmarkets.com/research/qwzt5g/endometriosis
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Women's Health


TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 



